Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

GSK

Company Type: Therapeutics

Main focus: Development of new therapies for infectious diseases, HIV, respiratory/immunology and oncology

Company stage: Clinical

Diseases: Infectious diseases, HIV, respiratory/immunology and oncology

Genome-editing tool: CRISPR-Cas9, RNA editing

Funding stage: IPO (GSK)

Location: Brentford, UK

Website: https://www.gsk.com/en-gb/

Pipeline: https://www.gsk.com/en-gb/innovation/pipeline/

Partners: Wave Life Sciences, University of California (Jennifer Doudna)

GSK is a global biopharma company with a goal to unite science, technology and talent to advance novel therapies. The company seeks innovation in vaccines and specialty medicines to prevent and treat disease.

Tags

HashtagGSK

Company: GSK
close
Search CRISPR Medicine